Your browser is no longer supported. Please, upgrade your browser.
Settings
PEN [NYSE]
Penumbra, Inc.
Index- P/E- EPS (ttm)-0.44 Insider Own1.60% Shs Outstand36.36M Perf Week-6.16%
Market Cap9.74B Forward P/E173.66 EPS next Y1.54 Insider Trans-12.63% Shs Float33.94M Perf Month9.66%
Income-15.70M PEG- EPS next Q0.09 Inst Own95.00% Short Float9.79% Perf Quarter30.05%
Sales560.40M P/S17.37 EPS this Y-132.90% Inst Trans6.04% Short Ratio4.20 Perf Half Y24.60%
Book/sh17.64 P/B15.13 EPS next Y109.12% ROA-2.00% Target Price310.00 Perf Year51.58%
Cash/sh7.26 P/C36.76 EPS next 5Y28.80% ROE-2.60% 52W Range121.80 - 314.22 Perf YTD52.52%
Dividend- P/FCF- EPS past 5Y-50.60% ROI-3.00% 52W High-15.06% Beta0.24
Dividend %- Quick Ratio3.80 Sales past 5Y24.70% Gross Margin60.30% 52W Low119.14% ATR14.77
Employees3300 Current Ratio5.80 Sales Q/Q14.90% Oper. Margin-7.00% RSI (14)49.73 Volatility5.10% 4.63%
OptionableYes Debt/Eq0.04 EPS Q/Q-62.40% Profit Margin-2.80% Rel Volume0.37 Prev Close263.24
ShortableYes LT Debt/Eq0.04 EarningsFeb 23 AMC Payout- Avg Volume790.98K Price266.91
Recom1.90 SMA20-3.23% SMA5010.70% SMA20023.30% Volume293,002 Change1.39%
Dec-16-20Downgrade BTIG Research Buy → Neutral
Oct-07-20Resumed Canaccord Genuity Buy $253
Sep-29-20Initiated BTIG Research Buy $233
Sep-08-20Downgrade BofA Securities Buy → Neutral
Mar-05-20Initiated Citigroup Buy $200
Jun-13-19Reiterated BofA/Merrill Buy $150 → $180
May-30-19Upgrade JP Morgan Neutral → Overweight
May-21-19Initiated William Blair Outperform
Oct-29-18Resumed BofA/Merrill Buy $36
Oct-08-18Initiated RBC Capital Mkts Outperform $174
Feb-21-18Initiated William Blair Outperform
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Nov-30-15Reiterated Canaccord Genuity Buy $50 → $58
Oct-13-15Initiated Wells Fargo Outperform
Mar-06-21 01:00PM  
12:50PM  
11:53AM  
08:38AM  
Mar-05-21 10:50PM  
08:18PM  
06:45PM  
06:00PM  
12:00PM  
11:50AM  
11:30AM  
08:46AM  
06:07AM  
12:15AM  
Mar-04-21 10:50PM  
07:52PM  
07:01PM  
04:04PM  
02:30PM  
01:20PM  
01:00PM  
12:25PM  
12:09PM  
11:45AM  
11:04AM  
11:00AM  
06:30AM  
12:15AM  
Mar-03-21 10:50PM  
10:11PM  
07:16PM  
06:18PM  
04:00PM  
03:38PM  
02:09PM  
01:45PM  
12:45PM  
11:15AM  
10:00AM  
07:30AM  
06:30AM  
Mar-02-21 10:50PM  
10:02PM  
08:34PM  
06:45PM  
05:49PM  
01:45PM  
12:30PM  
12:00PM  
11:00AM  
07:08AM  
06:20AM  
Mar-01-21 10:50PM  
07:06PM  
06:14PM  
05:14PM  
02:22PM  
02:01PM  
12:55PM  
12:00PM  
11:27AM  
11:19AM  
10:00AM  
06:19AM  
12:20AM  
Feb-28-21 08:12PM  
02:35PM  
08:52AM  
Feb-27-21 05:00PM  
04:22PM  
08:22AM  
Feb-26-21 10:50PM  
08:54PM  
07:14PM  
06:00PM  
01:20PM  
12:36PM  
11:15AM  
06:40AM  
Feb-25-21 10:50PM  
07:30PM  
05:58PM  
04:33PM  
01:00PM  
12:45PM  
12:30PM  
11:15AM  
10:30AM  
09:35AM  
06:30AM  
Feb-24-21 10:50PM  
06:15PM  
05:00PM  
04:46PM  
02:50PM  
02:17PM  
02:12PM  
12:40PM  
11:25AM  
06:16AM  
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; rehabilitation tools that displays and tracks upper-extremity rehabilitation exercises under the REAL Immersive System brand name; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand name, as well as a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and POD Packing Coil brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bose AraniChief InnovatorFeb 01Sale259.4310,0002,594,271530,662Feb 03 07:22 PM
Pray James RobertPresident, InternationalFeb 01Sale259.645,0001,298,199423,431Feb 03 07:22 PM
Bose AraniChief InnovatorJan 25Sale255.8110,0002,558,100540,662Jan 27 06:58 PM
Grewal HarpreetDirectorJan 04Sale174.32633110,34512,195Jan 06 07:47 PM
Wilder ThomasDirectorJan 04Sale174.3211520,047148Jan 06 07:48 PM
Pray James RobertPresident, InternationalJan 04Sale174.555,000872,743428,431Jan 06 07:43 PM
O'Rourke BridgetDirectorDec 14Sale190.886512,4073,063Dec 16 09:04 PM
Elsesser AdamCEO and PresidentDec 11Sale190.708,0001,525,574957,582Dec 14 09:34 PM
Pray James RobertPresident, InternationalDec 01Sale215.935,0001,079,655433,431Dec 03 08:41 PM
Rothman LynnEVP and Chief Business OfficerNov 24Option Exercise3.9810,15040,39722,482Nov 25 08:33 PM
Pray James RobertPresident, InternationalNov 17Sale258.615,0001,293,039438,431Nov 19 08:37 PM
Grewal HarpreetDirectorNov 16Sale262.77567148,99112,828Nov 18 08:38 PM
O'Rourke BridgetDirectorNov 13Sale271.466517,6453,128Nov 17 08:34 PM
Elsesser AdamCEO and PresidentNov 11Sale265.168,0002,121,260965,582Nov 13 09:06 PM
Bose AraniChief InnovatorNov 10Sale255.437,9982,042,957550,662Nov 13 09:03 PM
Bose AraniChief InnovatorNov 09Sale255.9910025,599558,660Nov 09 09:03 PM
Bose AraniChief InnovatorNov 05Sale255.191,902485,371558,760Nov 09 09:03 PM
O'Rourke BridgetDirectorOct 13Sale207.586513,4933,193Oct 15 08:23 PM
Elsesser AdamCEO and PresidentOct 12Sale212.648,0001,701,146973,582Oct 14 08:51 PM
Kassing Don W.DirectorOct 09Sale209.76712149,347993Oct 14 08:46 PM
Wilder ThomasDirectorOct 01Sale196.0611522,547263Oct 05 08:48 PM
O'Rourke BridgetDirectorSep 14Sale200.976513,0633,258Sep 16 07:49 PM
Elsesser AdamCEO and PresidentSep 11Sale200.738,0001,605,862981,582Sep 15 08:52 PM
Pray James RobertPresident, InternationalSep 01Sale212.745,0001,063,678443,431Sep 03 08:13 PM
Pray James RobertPresident, InternationalAug 18Sale235.115,0001,175,537448,431Aug 20 07:39 PM
Roberts JohannaEVP, Gen. Counsel & SecretaryAug 17Sale236.072,000472,14550,761Aug 19 08:21 PM
O'Rourke BridgetDirectorAug 13Sale237.166515,4153,323Aug 17 08:54 PM
Elsesser AdamCEO and PresidentAug 11Sale232.158,0001,857,160989,582Aug 13 09:18 PM
Rothman LynnEVP and Chief Business OfficerJul 20Option Exercise3.984,87519,40217,207Jul 21 09:42 PM
Rothman LynnEVP and Chief Business OfficerJul 20Sale200.074,875975,34112,332Jul 21 09:42 PM
Rothman LynnEVP and Chief Business OfficerJul 17Option Exercise3.984,80019,10417,132Jul 21 09:42 PM
O'Rourke BridgetDirectorJul 17Sale189.23468,7053,388Jul 21 09:39 PM
Rothman LynnEVP and Chief Business OfficerJul 17Sale195.124,800936,57612,332Jul 21 09:42 PM
Rothman LynnEVP and Chief Business OfficerJul 13Option Exercise3.9820079612,532Jul 15 08:53 PM
O'Rourke BridgetDirectorJul 13Sale192.4718936,3773,434Jul 15 08:45 PM
Wilder ThomasDirectorJul 13Sale192.4723044,268526Jul 15 08:48 PM
Elsesser AdamCEO and PresidentJul 13Sale191.908,0001,535,167997,582Jul 15 08:50 PM
Rothman LynnEVP and Chief Business OfficerJul 13Sale195.0020039,00012,332Jul 15 08:53 PM
Elsesser AdamCEO and PresidentJun 11Sale166.888,0001,335,0621,005,582Jun 15 08:35 PM
Elsesser AdamCEO and PresidentMay 11Sale187.678,0001,501,3561,013,582May 13 08:20 PM
Bose AraniChief InnovatorMay 07Sale185.0710,0001,850,700560,662May 11 08:12 PM
Bose AraniChief InnovatorApr 23Sale185.539,1001,688,286570,662Apr 27 08:23 PM
Bose AraniChief InnovatorApr 20Sale185.11900166,599579,762Apr 22 07:47 PM
Kosaraju SridharPresidentApr 15Sale169.282,500423,204155,351Apr 17 09:08 PM
Elsesser AdamChief Executive OfficerApr 13Sale157.818,0001,262,4931,021,582Apr 15 08:48 PM
O'Rourke BridgetDirectorApr 06Sale162.56447,1533,623Apr 08 08:06 PM
Kosaraju SridharPresidentMar 16Sale154.362,500385,901157,851Mar 18 07:55 PM
Elsesser AdamChief Executive OfficerMar 09Sale172.018,0001,376,0961,029,582Mar 11 08:10 PM